Duloxetine for OCD
About this title
Duloxetine for the Treatment of Obsessive Compulsive Disorder (OCD)
Read the official source — NCT00464698Researchers studied Duloxetine to find out how it affected obsessive thoughts and compulsive behaviours in people with OCD.
Understand this study
What did researchers investigate?
Researchers studied Duloxetine to find out how it affected obsessive thoughts and compulsive behaviours in people with OCD.
Who was this study for?
This study was for people with OCD. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
- Listed locations
- BostonSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
- Recruitment status
- Completed
- Enrollment listed in the registry
- 20
- Sponsor
- Massachusetts General Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00464698
- Official title
Show the full official title
Duloxetine for the Treatment of Obsessive Compulsive Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
Boston
Interested in joining this study?
Questions about this study
What did researchers investigate?
Researchers studied Duloxetine to find out how it affected obsessive thoughts and compulsive behaviours in people with OCD.
Who is behind this study?
The study sponsor is Massachusetts General Hospital, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including Duloxetine.
Who was this study for?
This study was for people with OCD. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
